RecruitingIron Deficiency AnemiaPregnancy
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
Eligible age
18–45 yrs
Accepts
Women
Locations
7 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Double blind, placebo controlled, multicenter randomized trial in pregnant women in the U.S. (N=300) to test the central hypothesis that IV iron in pregnant women with IDA (Hb\<11 g/dL and ferritin\<30 ng/mL) at 13 - 30 weeks will be effective, safe and cost-effective in reducing severe maternal morbidity-as measured by maternal anemia at delivery-and will also improve offspring neurodevelopment.
Sponsor: Women and Infants Hospital of Rhode Island
You may qualify if…
- ✓ Pregnant women between the ages of 18-45
- ✓ Singleton gestation
- ✓ Iron-deficiency anemia (serum ferritin \<30ng/mL and Hb\<11 g/dL)
- ✓ At 13-30 weeks gestation
- ✓ Plan to deliver at participating hospital
You may not qualify if…
- ✕ Non-iron-deficiency anemia e.g thalassemia, sickle cell disease, B12 or folate deficiency, hypersplenism.
- ✕ Malabsorptive syndrome, inflammatory bowel disease, gastric bypass, or sensitivity to oral or IV iron
- ✕ Multiple gestation
- ✕ Inability or unwillingness to provide informed consent
- ✕ Inability to communicate with members of the study team, despite the presence of an interpreter
- ✕ Planned delivery at a non-study affiliated hospital
Where it's recruiting
Source: ClinicalTrials.gov · NCT05462704 · last updated 2025-06-10